Author:
Shui Irene M.,Mucci Lorelei A.,Kraft Peter,Tamimi Rulla M.,Lindstrom Sara,Penney Kathryn L.,Nimptsch Katharina,Hollis Bruce W.,DuPre Natalie,Platz Elizabeth A.,Stampfer Meir J.,Giovannucci Edward
Publisher
Oxford University Press (OUP)
Reference39 articles.
1. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1alpha,25-dihydroxyvitamin D3;Hsu;Am J Pathol.,2011
2. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer;Chen;Clin Cancer Res.,2000
3. Treatment of K562 cells with 1,25-dihydroxyvitamin D(3) induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCL(XL), and p21;Kizildag;Ann Hematol.,2010
4. Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression;Krishnan;J Cell Biochem.,2003
5. Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis;Gilbert;Cancer Causes Control.,2011
Cited by
144 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献